PHERAZINE W Drug Patent Profile
✉ Email this page to a colleague
When do Pherazine W patents expire, and when can generic versions of Pherazine W launch?
Pherazine W is a drug marketed by Halsey and is included in one NDA.
The generic ingredient in PHERAZINE W is codeine phosphate; promethazine hydrochloride. There are nineteen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the codeine phosphate; promethazine hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PHERAZINE W?
- What are the global sales for PHERAZINE W?
- What is Average Wholesale Price for PHERAZINE W?
Summary for PHERAZINE W
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | PHERAZINE W at DailyMed |
US Patents and Regulatory Information for PHERAZINE W
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | PHERAZINE W/ CODEINE | codeine phosphate; promethazine hydrochloride | SYRUP;ORAL | 088739-001 | Dec 23, 1988 | DISCN | No | No | ⤷ Get Started Free | ⤷ Get Started Free | ⤷ Get Started Free | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
